Alternating Diet as a Preventive and Therapeutic Intervention for High Fat Diet-induced Metabolic Disorder

被引:5
作者
Ma, Yongjie [1 ]
Gao, Mingming [1 ]
Liu, Dexi [1 ]
机构
[1] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
INDUCED HEPATIC STEATOSIS; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CALORIE RESTRICTION; OXIDATIVE STRESS; WEIGHT-LOSS; GAMMA; EXPRESSION; OBESITY;
D O I
10.1038/srep26325
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study presents the alternating diet as a new strategy in combating obesity and metabolic diseases. Lean or obese mice were fed a high-fat diet (HFD) for five days and switched to a regular diet for one (5 + 1), two (5 + 2), or five (5 + 5) days before switching back to HFD to start the second cycle, for a total of eight weeks (for prevention) or five weeks (for treatment) without limiting animals' access to food. Our results showed that animals with 5 + 2 and 5 + 5 diet alternations significantly inhibited body weight and fat mass gain compared to animals fed an HFD continuously. The dietary switch changed the pattern of daily caloric intake and suppressed HFD-induced adipose macrophage infiltration and chronic inflammation, resulting in improved insulin sensitivity and alleviated fatty liver. Alternating diet inhibited HFD-induced hepatic Ppar gamma-mediated lipid accumulation and activated the expression of Ppar alpha and its target genes. Alternating diet in the 5 + 5 schedule induced weight loss in obese mice and reversed the progression of metabolic disorders, including hepatic steatosis, glucose intolerance, and inflammation. The results provide direct evidence to support that alternating diet represents a new intervention in dealing with the prevalence of diet-induced obesity.
引用
收藏
页数:14
相关论文
共 41 条
  • [21] PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
    Kawai, Masanobu
    Rosen, Clifford J.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (11) : 629 - 636
  • [22] Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
    Kersten, S
    Seydoux, J
    Peters, JM
    Gonzalez, FJ
    Desvergne, B
    Wrahli, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) : 1489 - 1498
  • [23] Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet
    Klempel, Monica C.
    Kroeger, Cynthia M.
    Varady, Krista A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (01): : 137 - 143
  • [24] Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
    Koonen, Debby P. Y.
    Jacobs, Rene L.
    Febbraio, Maria
    Young, Martin E.
    Soltys, Carrie-Lynn M.
    Ong, Huy
    Vance, Dennis E.
    Dyck, Jason R. B.
    [J]. DIABETES, 2007, 56 (12) : 2863 - 2871
  • [25] Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
    Lee, Byung-Cheol
    Lee, Jongsoon
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (03): : 446 - 462
  • [26] Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
    Lee, Yoo Jeong
    Ko, Eun Hee
    Kim, Ji Eun
    Kim, Eunha
    Lee, Hyemin
    Choi, Hyeonjin
    Yu, Jung Hwan
    Kim, Hyo Jung
    Seong, Je-Kyung
    Kim, Kyung-Sup
    Kim, Jae-Woo
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (34) : 13656 - 13661
  • [27] Chlorogenic Acid Improves High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
    Ma, Yongjie
    Gao, Mingming
    Liu, Dexi
    [J]. PHARMACEUTICAL RESEARCH, 2015, 32 (04) : 1200 - 1209
  • [28] Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
    Matsusue, K
    Haluzik, M
    Lambert, G
    Yim, SH
    Gavrilova, O
    Ward, JM
    Brewer, B
    Reitman, ML
    Gonzalez, FJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) : 737 - 747
  • [29] Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
    Moran-Salvador, Eva
    Lopez-Parra, Marta
    Garcia-Alonso, Veronica
    Titos, Esther
    Martinez-Clemente, Marcos
    Gonzalez-Periz, Ana
    Lopez-Vicario, Cristina
    Barak, Yaacov
    Arroyo, Vicente
    Claria, Joan
    [J]. FASEB JOURNAL, 2011, 25 (08) : 2538 - 2550
  • [30] Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
    Ng, Marie
    Fleming, Tom
    Robinson, Margaret
    Thomson, Blake
    Graetz, Nicholas
    Margono, Christopher
    Mullany, Erin C.
    Biryukov, Stan
    Abbafati, Cristiana
    Abera, Semaw Ferede
    Abraham, Jerry P.
    Abu-Rmeileh, Niveen M. E.
    Achoki, Tom
    AlBuhairan, Fadia S.
    Alemu, Zewdie A.
    Alfonso, Rafael
    Ali, Mohammed K.
    Ali, Raghib
    Alvis Guzman, Nelson
    Ammar, Walid
    Anwari, Palwaslia
    Banerjee, Amitava
    Barquera, Simon
    Basu, Sanjay
    Bennett, Derrick A.
    Bhutta, Zulfiqar
    Blore, Jed
    Cabral, Norberto
    Campos Nonato, Ismael
    Chang, Jung-Chen
    Chowdhury, Rajiv
    Courville, Karen J.
    Criqui, Michael H.
    Cundiff, David K.
    Dabhadkar, Kaustubh C.
    Dandona, Lalit
    Davis, Adrian
    Dayama, Anand
    Dharmaratne, Samath D.
    Ding, Eric L.
    Durrani, Adnan M.
    Esteghamati, Alireza
    Farzadfar, Farshad
    Fay, Derek F. J.
    Feigin, Valery L.
    Flaxman, Abraham
    Forouzanfar, Mohammad H.
    Goto, Atsushi
    Green, Mark A.
    Gupta, Rajeev
    [J]. LANCET, 2014, 384 (9945) : 766 - 781